Effects of lexipafant (BB-882), a platelet activating factor receptor antagonist, on liver damage due to bile duct ligation in rats

Acta Gastro-Enterologica Belgica

Volumn 69, Issue 2, 2006, Pages 197-202

  Öztürk, Hulya ^a   Öztürk, Hayrettin ^b,d   Dokucu, Ali Ihsan ^c   Otcu, Selcuk ^b  

^a Diyarbakir Children Hospital   (Turkey)

^b DICLE UNIVERSITY   (Turkey)

^c SISLI ETFAL TRAINING AND RESEARCH HOSPITAL   (Turkey)

^d ABANT IZZET BAYSAL UNIVERSITY   (Turkey)

Author keywords

BB 882; Bile duct ligation; Lexipafant; Rat

Indexed keywords

BILIRUBIN; CATALASE; GLUTATHIONE PEROXIDASE; LEXIPAFANT; LIVER ENZYME; SUPEROXIDE DISMUTASE; THROMBOCYTE ACTIVATING FACTOR ANTAGONIST;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE DUCT LIGATION; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DISEASE SEVERITY; DRUG ACTIVITY; DRUG ANTAGONISM; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG MECHANISM; ENZYME BLOOD LEVEL; FIBROSIS; HISTOPATHOLOGY; INFLAMMATION; LAPAROTOMY; LIVER INJURY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN INTERACTION; RAT; TREATMENT OUTCOME;

ALANINE TRANSAMINASE; ALKALINE PHOSPHATASE; ANIMALS; ASPARTATE AMINOTRANSFERASES; BILIRUBIN; CATALASE; CHOLESTASIS, EXTRAHEPATIC; DISEASE MODELS, ANIMAL; GAMMA-GLUTAMYLTRANSFERASE; GLUTATHIONE PEROXIDASE; IMIDAZOLES; LEUCINE; LIGATION; LIVER CIRRHOSIS; MALE; NEUTROPHILS; PLATELET MEMBRANE GLYCOPROTEINS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, G-PROTEIN-COUPLED; SUPEROXIDE DISMUTASE;

EID: 33747621139     PISSN: 00015644     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (37)

1. ARONSON C.D., DE HAAN J., JAMES J. Quantitative aspects of the parenchymal-stroma relationship in experimentally induced cholestasis. Liver, 1988, 8: 116-126.
2. TUCHWEBER B., DESMOULIERE A., BOCHATON-PIALLAT M.L., RUBBIA-BRANDT L., GABBIANI G. Proliferation and phenotypic modulation of portal fibroblasts in the early stages of cholestatic fibrosis in the rat. Lab. Invest., 1996, 74: 265-78.
3. LIU T.Z., LEE K.T., CHERN C.L., CHENG J.T., STERN A., TSAI L.Y. Free radical-triggered hepatic injury of experimental obstructive jaundice of rats involves overproduction of proinflammatory cytokines and enhanced activation of nuclear factor kappa B. Ann. Clin. Lab. Sci., 2001, 31: 383-90.
4. VENDEMIALE G., GRATTAGLIANO I., LUPO L., MEMEO V., ALTOMARE E. Hepatic oxidative alterations in patients with extra-hepatic cholestasis. Effect of surgical drainage. J. Hepatol., 2002, 37: 601-5.
5. FUKUOKA T., NAKAJIMA Y., HORIKAWA M., AOMATSU Y., YOSHIMURA A., UENO M., KO S., NAKANO H. Platelet activating factor mediates systemic circulatory collapse after temporary hepatic inflow occlusion. Transplantation Proceedings, 1993, 25: 1809-1810.
6. FUJIMURA K., KUBOTA Y., OGURA M., YAMAGUCHI T., BINNAKA T., TANI K., KITAGAWA S., MIZUNO T., INOUE K. Role of endogenous platelet-activating factor (PAF) in endotoxin-induced portal hypertension in rats. J. Gastroenterol. Hepatol., 1992, 7: 481-5.
7. ISHIGURO S., ARII S., MONDEN K., ADACHI Y., FUNAKI N., HIGASHITSUJI H., FUJITA S., FURUTANI M., MISE M., KITAO T. et al. Identification of the thromboxane A2 receptor in hepatic sinusoidal endothelial cells and its role in endotoxin-induced liver injury in rats. Hepatology, 1994, 20: 1281-6.
8. ISHIGURO S., ARII S., MONDEN K., FUJITA S., NAKAMURA T., NIWANO M., HARADA T., USHIKUBI F., NARUMIYA S., IMAMURA M. Involvement of thromboxane A2 receptor system of the hepatic sinusoid in pathogenesis of cold preservation/reperfusion injury in the rat liver graft. Transplantation, 1995, 59: 957-61.
9. IWAZAKI S., TAKEYOSHI I., OHWADA S., SUNOSE Y., TSUTSUMI H., KAWASHIMA Y., MATSUMOTO K., MORISHITA Y. FR128998 ameliorates liver injury in extended liver resection with ischemia in dogs. Hepatogastroenterology, 2001, 48: 197-202.
10. TAKEYOSHI I., SUNOSE Y., IWAZAKI S., TSUTSUMI H., AIBA M., KASAHARA M., OHWADA S., MATSUMOTO K., MORISHITA Y. The effect of a selective cycloxygenase-2 inhibitor in extended liver resection with ischemia in dogs. J. Surg. Res., 2001, 100: 25-31.
11. RABINOVICI R., SOFRONSKI M.D., RENZ J.F., HILLEGAS L.M., ESSER KM., VERNICK J., FEUERSTEIN G. Platelet activating factor mediates interleukin-2-induced lung injury in the rat. J. Clin. Invest., 1992, 89: 1669-1673.
12. NOGUCHI K., MATSUZAKI T., SHIROMA N., OJIRI Y., SAKANASHI M. Involvement of nitric oxide and eicosanoids in platelet-activating factor-induced haemodynamic and haematological effects in dogs. Br. J. Pharmacol., 1996, 118: 941-949, discussion, 949-950.
13. DUNON D., PIALI L., IMHOF B.A. To stick or not to suck: the new leukocyte homing paradigm. Curr. Opin. Cell Biol., 1996, 8: 714-23.
14. CRIADO M., FLORES O., ORTIZ M.C., HIDALGO F., RODRIGUEZ-LOPEZ A.M., ELENO N., ATUCHA N.M., SANCHEZ-RODRIGUEZ A., AREVALO M., GARCIA-ESTAN J., LOPEZ-NOVOA J.M. Elevated glomerular and blood mononuclear lymphocyte nitric oxide production in rats with chronic bile duct ligation: role of inducible nitric oxide synthase activation. Hepatology, 1997, 262: 268-276.
15. HERNANDEZ-MUNOZ R, DIAZ-MUNOZ M, LOPEZ V. Balance between oxidative damage and proliferative potential in an experimental rat model of CC14-induced cirrhosis: protective role of adenosine administration. Hepatology, 1997, 26: 1100-10.
16. MISRA H.P., FRIDOVICH I. The role of superoxide anion in the autoxidation of epinephrine and a simple assay for superoxide dismutase. J. Biol. Chem., 1972, 247: 3170-5.
17. BEERS R.F. Jr, SIZER I.W. A spectrophotometric method for measuring the breakdown of hydrogen peroxide by catalase. J. Biol. Chem., 1952, 195: 133-40.
18. ROTRUCK J.T., POPE A.L., GANTHER H.E., SWANSON A.B., HAFEMAN D.G., HOEKSTRA W.G. Selenium biochemical role as component of glutathione peroxidase. Science, 1973, 179: 588-90.
19. GREIM H., TRULZSCH D., ROBOZ J., DRESSLER K., CZYGAN P., HUTTERER F., SCHAFFNER F., POPPER H. Mechanisms of cholestasis 5. Bile acids in normal rat livers and in those after bile duct ligation. Gastroenterology, 1972, 63: 837-45.
20. MURIEL P., GONZÁLEZ P. Liver damage induced by acute cholestasis in the rat is ameliorated partially by L-arginine. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol., 1998, 120: 421-424.
21. KRAHENBUHL L., TALOS C., REICHEN J., KRAHENBUHL S. Progressive decrease in tissue glycogen content in rats with long-term cholestasis. Hepatology, 1996, 24: 902-7.
22. BARON V., MURIEL P. Role of glutathione, lipid peroxidation and antioxidants on acute bile-duct obstruction in the rat. Biochim. Biophys. Acta, 1999, 18: 173-180.
23. SINGH S., SHACKLETON G., AH-SING E., CHAKRABORTY J., BAILEY M.E. Antioxidant defenses in the bile duct-ligated rat. Gastroenterology, 1992, 103: 1625-1629.
24. COMPORTI M. Lipid peroxidation and cellular damage in toxic liver injury. Lab. Invest., 1985, 53: 599-623.
25. BURTON K.P., MORRIS A.C., MASSEY K.D., BUJA L.M., HAGER H.K. Free radicals alter ionic calcium levels and membrane phospholipids in cultured rat ventricular myocytes. J. Mol. Cell. Cardiol., 1990 ,22: 1035-47.
26. JANSSEN Y.M., VAN HOUTEN B., BORM P.J., MOSSMAN B.T. Cell and tissue responses to oxidative damage. Lab. Invest, 1993, 69: 261-74.
27. ERNSTER L., NORDENBRAND K. (eds). Microsomal lipid peroxidation. In Methods in Enzymology. Academic Press New York, 1967.
28. HARTUNG H.P., PARNHAM MJ., WINKELMANN J., ENGLBERGER W, HADDING U. Platelet activating factor (PAF) induces the oxidative burst in macrophages. Int. J. Immunopharmacol., 1983, 5: 115-21.
29. DROY-LEFAIX M.T., DROUET Y., GERAUD G., HOSFORD D., BRAQUET P. Superoxide dismutase (SOD) and the PAF-antagonist (BN52021) reduce small intestinal damage induced by ischemia reperfusion. Free Radic. Res. Commun., 1991, 12-13 (Part 2): 725-35.
30. SCHWAPPACH J.R., WOOD J.G., CHEUNG L.Y. Superoxide dismutase attenuates effects of platelet-activating factor on gastric microcirculation. J. Surg. Res., 1995, 59: 733-88.
31. HUANG Y.C., NOZIK E.S., PIANTADOSI C.A. Superoxide dismutase potentiates platelet-avtivating factor-induced injury in perfused lung. Am. J. Physiol., 1994, 266: L246-54.
32. SAITO J.M., MAHER J.J. Bile duct ligation in rats induces biliary expression of cytokine-induced neutrophil chemoattractant. Gastroenterology, 2000, 118: 1157-68.
33. PAROLA M., LEONARDUZZI G., ROBINO G., ALBANO E., POLI G., DIANZANI M.U. On the role of lipid peroxidation in the pathogenesis of liver damage induced by long-standing cholestasis. Free Radic. Biol. Med., 1996, 20: 351-/9.
34. SVEGLIATI-BARONI G., SACCOMANNO S., VAN GOOR H., JANSEN P., BENEDETTI A., MOSHAGE H. Involvement of reactive oxygen species and nitric oxide radicals in activation and proliferation of rat hepatic stellate cells. Liver, 2001, 21: 1-12.
35. GOMEZ-CHIARRI M., ORTIZA., LERMA J.L., LOPEZ-ARMADA M.J., MAMPASO F., GONZALEZ E., EGIDO J. Involvement of tumor necrosis factor and platelet-activating factor in the pathogenesis of experimental nephrosis in rats. Lab. Invest., 1994, 70: 449-457.
36. DUGERNIER T., REYNAERT M., LATERRE P.F. Early multi-system organ failure associated with acute pancreatitis: plea for a conservative therapeutic strategy. Acta Gastroenterol. Belg., 2003, 66, 177-183).
37. WANG X., SUN Z., BORJESSON A., ANDERSSON R. Inhibition of platelet-activating factor, intercellular adhesion molecule 1 and platelet endothelial cell adhesion molecule 1 reduces experimental pancreatitis- associated gut endothelial barrier dysfunction British Journal of Surgery, 1999, 86: 411-416.